Average Cost of GLP-1 Injections: Understanding Pricing Factors and Options
Learn what affects GLP-1 injection costs—including Ozempic®, Wegovy®, and Rybelsus®—plus insurance tips, savings options, and licensed healthcare access via Eden.
- Monthly semaglutide costs range from $900–$1,800 without insurance, and as low as $25–$300 with commercial coverage, depending on your plan.
- Pricing varies by formulation: Ozempic® ($800–$1,000), Wegovy® ($1,300–$1,500), and Rybelsus® (~$850–$950); please note that this pricing is accurate at the time of publishing. Pricing may fluctuate post-publishing. Please check with your licensed healthcare provider, insurance provider, or Novo Nordisk for accurate information.
- Medicare typically covers semaglutide only for type 2 diabetes; Medicaid coverage varies by state.
- Eden facilitates access to transparent pricing, connects users to licensed providers for eligibility evaluation, and supports referral to accredited pharmacies. Please note that Eden is not a pharmacy or medical provider. You may connect with licensed healthcare providers through the Eden network to determine whether or not you are an eligible candidate for GLP-1 medications. Eligibility is not guaranteed.
Understanding Semaglutide and Its Uses
Semaglutide is a GLP-1 receptor agonist that helps manage:
- Type 2 diabetes (Ozempic®, Rybelsus®)
- Obesity and overweight with related health conditions (Wegovy®)
Semaglutide is FDA-approved for type 2 diabetes (Ozempic®, Rybelsus®) and chronic weight management in individuals with obesity or overweight with related conditions (Wegovy®). These medications work through GLP-1 receptor activity and must be prescribed and monitored by a licensed healthcare provider.
Explore GLP-1 medication options with licensed healthcare providers whom you may connect with via Eden’s platform.
Semaglutide Pricing by Product
Prices reflect typical U.S. retail costs without discounts or insurance and may vary by dose.
{{primary-cta}}
Cost Overview by Insurance Type
Medicare generally does not cover semaglutide for weight management unless prescribed for type 2 diabetes. Medicaid eligibility and coverage vary by state.
Pricing Factors That Influence Semaglutide Cost
Medicare and Medicaid Coverage
- Medicare Part D may cover Ozempic® and Rybelsus® for type 2 diabetes only
- Wegovy® is generally not covered by Medicare, which excludes weight-loss medications.
- Medicaid may approve Wegovy® for obesity treatment in some states with prior authorization.
Cost-Saving Strategies
1. Manufacturer Copay Cards
Novo Nordisk may offer savings programs for eligible commercially insured patients:
Individuals without commercial insurance may qualify for income-based assistance programs.
2. Compare Pharmacies
- Use price-comparison tools such as GoodRx or SingleCare to view estimated out-of-pocket costs at different pharmacies.
- Ask your local pharmacy whether they offer cash discounts for self-pay options.
- In some cases, independent or mail-order pharmacies may provide lower prices than larger retail chains. Be sure to verify that any pharmacy you choose is licensed and accredited.
3. Discuss Alternatives
- Consider oral options (e.g., Rybelsus®)
- Ask about other GLP-1s or GIP/GLP-1 dual agonists like tirzepatide.
- Explore metabolic combo therapies (e.g., metformin, bupropion, topiramate). Always consult a licensed healthcare provider before considering combination therapies or alternative medications.
{{primary-cta}}
Yearly Cost Estimates and Planning
Some studies suggest that GLP-1 therapy may have long-term health benefits for individuals with diabetes or obesity; consult with a licensed provider to understand what treatment may be appropriate for your health profile. (PubMed, 2019).
Final Thoughts
The average cost of GLP-1 injections varies widely, from $900 to $1,800/month without insurance to under $300/month with coverage or compounding access. Factors such as brand, dosage, and insurance eligibility significantly affect pricing.
For safe, cost-effective access, work with a licensed healthcare provider who may:
- Help you navigate insurance
- Select the appropriate formulation, when eligible
- Refer you to a reliable pharmacy
- Monitor your progress and adjust treatment as needed
Eden connects users with vetted healthcare professionals and supports the treatment journey from start to finish.
Explore your GLP-1 treatment options
This article is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider for medical guidance and speak with your insurance provider to understand your coverage options. Eden does not practice medicine or dispense medications. Eden connects users with licensed healthcare providers who determine treatment eligibility and refer prescriptions to accredited pharmacies.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
Eden is not a medical provider. Eden connects individuals with independent licensed healthcare providers who independently evaluate each patient to determine whether a prescription treatment program is appropriate. All prescriptions are written at the sole discretion of the licensed provider. Medications are filled by state-licensed pharmacies. Please consult a licensed healthcare provider before making any medical decisions.
Frequently asked questions
Depending on the dose and formulation, it ranges from $900 to $1,800.
Only for type 2 diabetes. Wegovy® for weight loss is excluded from Medicare Part D.
No. Manufacturer copay programs are only available to individuals with commercial insurance. Patients on Medicare or Medicaid may need to explore alternative savings or support programs.
No. Semaglutide remains under patent protection, with expiration dates ranging from 2026 to 2033 depending on the product (e.g., Ozempic®, Wegovy®, Rybelsus®). Until then, only brand-name versions are available.
Blog Components
